Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines ; volume:12 ; number:1 ; day:5 ; month:7 ; year:2022 ; pages:1-12 ; date:12.2022
Scientific reports ; 12, Heft 1 (5.7.2022), 1-12, 12.2022
- Creator
-
Jantalika, Tanachapa
Manochantr, Sirikul
Kheolamai, Pakpoom
Tantikanlayaporn, Duangrat
Saijuntha, Weerachai
Pinlaor, Somchai
Chairoungdua, Arthit
Paraoan, Luminita
Tantrawatpan, Chairat
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-15298-0
- URN
-
urn:nbn:de:101:1-2022082421133170974478
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2022, 7:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jantalika, Tanachapa
- Manochantr, Sirikul
- Kheolamai, Pakpoom
- Tantikanlayaporn, Duangrat
- Saijuntha, Weerachai
- Pinlaor, Somchai
- Chairoungdua, Arthit
- Paraoan, Luminita
- Tantrawatpan, Chairat
- SpringerLink (Online service)
Other Objects (12)
PI3K-AKT, JAK2-STAT3 pathways and cell–cell contact regulate maspin subcellular localization
PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway
Modulation of esophageal squamous cell carcinoma progression: the impact of CCR7 on JAK2/STAT3 signaling pathway
Oncostatin M promotes osteogenic differentiation of tendon-derived stem cells through the JAK2/STAT3 signalling pathway
The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway
β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo
PI3K-AKT, JAK2-STAT3 pathways and cell–cell contact regulate maspin subcellular localization
PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway
Modulation of esophageal squamous cell carcinoma progression: the impact of CCR7 on JAK2/STAT3 signaling pathway
Oncostatin M promotes osteogenic differentiation of tendon-derived stem cells through the JAK2/STAT3 signalling pathway
The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway
β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo
PI3K-AKT, JAK2-STAT3 pathways and cell–cell contact regulate maspin subcellular localization
PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway
Modulation of esophageal squamous cell carcinoma progression: the impact of CCR7 on JAK2/STAT3 signaling pathway
Oncostatin M promotes osteogenic differentiation of tendon-derived stem cells through the JAK2/STAT3 signalling pathway
The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway